Clinical Trials Logo

Urticaria clinical trials

View clinical trials related to Urticaria.

Filter by:

NCT ID: NCT00264303 Completed - Clinical trials for Chronic Idiopathic Urticaria

CUTE (Chronic Urticaria Treatment Evaluation)

Start date: December 2005
Phase: Phase 4
Study type: Interventional

A study to compare the clinical efficacy and safety of Levocetirizine vs. Desloratadine in patients suffering from Chronic Idiopathic Urticaria (CIU) measured by the mean pruritus severity score over the first week of treatment

NCT ID: NCT00214851 Completed - Clinical trials for Familial Cold Urticaria

The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria

Start date: September 2005
Phase: Phase 1
Study type: Interventional

An open labelled trial of Kineret (anakinra) induction therapy (100mg./day) in over a four week period in the treatment of Familial Cold Urticaria. Familial Cold Urticaria (FCU) is a rare autosomal dominant condition manifesting symptoms triggered by exposure to cold and variable in expression. Currently there is no standard reliable agent available for the treatment of patients with FCU.This study will evaluate the efficacy of Kineret (anakinra), an interleukin 1 receptor antagonist in induction and maintenance therapy in patients with FCU.

NCT ID: NCT00130234 Completed - Urticaria Clinical Trials

Effect of Anti-IgE in Chronic Urticaria

Start date: November 2004
Phase: Phase 2
Study type: Interventional

This study is being done to find out if a drug called Xolair (omalizumab), an anti-IgE antibody, is safe and effective for people with chronic urticaria (hives) with persistent symptoms in spite of taking antihistamines.

NCT ID: NCT00001150 Completed - Healthy Clinical Trials

Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers

Start date: October 1976
Phase: N/A
Study type: Observational

The use of a suction blister apparatus has facilitated study of the immunologic capacity of human epidermal cells. We have been able to prepare purified populations of these cells after blister formation. Specifically, using the blister tops, we are able to enrich for epidermal Langerhans cells which are very potent stimulators in antigen presenting assays. Thus, this normal volunteer study provides an important source of fresh epidermal tissue from which we can study normal epidermal Langerhans cell function. In addition, we have recently used blister roofs in important experimental models of HIV-1 transmission. There is no other method available for assessing the biologic function of freshly isolated Langerhans cells without altering their milieu. It is a very safe and effective way to obtain human epidermal samples.